189 related articles for article (PubMed ID: 38162654)
1. Type I Interferons induce endothelial destabilization in Systemic Lupus Erythematosus in a Tie2-dependent manner.
Rafael-Vidal C; Martínez-Ramos S; Malvar-Fernández B; Altabás-González I; Mouriño C; Veale DJ; Floudas A; Fearon U; Reigosa JMP; García S
Front Immunol; 2023; 14():1277267. PubMed ID: 38162654
[TBL] [Abstract][Full Text] [Related]
2. Tie1 controls angiopoietin function in vascular remodeling and inflammation.
Korhonen EA; Lampinen A; Giri H; Anisimov A; Kim M; Allen B; Fang S; D'Amico G; Sipilä TJ; Lohela M; Strandin T; Vaheri A; Ylä-Herttuala S; Koh GY; McDonald DM; Alitalo K; Saharinen P
J Clin Invest; 2016 Sep; 126(9):3495-510. PubMed ID: 27548530
[TBL] [Abstract][Full Text] [Related]
3. The Tie2 receptor antagonist angiopoietin 2 facilitates vascular inflammation in systemic lupus erythematosus.
Kümpers P; David S; Haubitz M; Hellpap J; Horn R; Bröcker V; Schiffer M; Haller H; Witte T
Ann Rheum Dis; 2009 Oct; 68(10):1638-43. PubMed ID: 18930996
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine phosphatase beta regulates angiopoietin-Tie2 signaling in human endothelial cells.
Yacyshyn OK; Lai PF; Forse K; Teichert-Kuliszewska K; Jurasz P; Stewart DJ
Angiogenesis; 2009; 12(1):25-33. PubMed ID: 19116766
[TBL] [Abstract][Full Text] [Related]
5. Tie1 regulates the Tie2 agonistic role of angiopoietin-2 in human lymphatic endothelial cells.
Song SH; Kim KL; Lee KA; Suh W
Biochem Biophys Res Commun; 2012 Mar; 419(2):281-6. PubMed ID: 22342979
[TBL] [Abstract][Full Text] [Related]
6. Artesunate inhibits type I interferon-induced production of macrophage migration inhibitory factor in patients with systemic lupus erythematosus.
Feng X; Chen W; Xiao L; Gu F; Huang J; Tsao BP; Sun L
Lupus; 2017 Jan; 26(1):62-72. PubMed ID: 27230555
[TBL] [Abstract][Full Text] [Related]
7. The molecular balance between receptor tyrosine kinases Tie1 and Tie2 is dynamically controlled by VEGF and TNFα and regulates angiopoietin signalling.
Singh H; Hansen TM; Patel N; Brindle NP
PLoS One; 2012; 7(1):e29319. PubMed ID: 22235284
[TBL] [Abstract][Full Text] [Related]
8. Tie2 as a novel key factor of microangiopathy in systemic sclerosis.
Moritz F; Schniering J; Distler JHW; Gay RE; Gay S; Distler O; Maurer B
Arthritis Res Ther; 2017 May; 19(1):105. PubMed ID: 28545512
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
[TBL] [Abstract][Full Text] [Related]
10. Anti-angiogenic properties of a sulindac analogue.
Pyriochou A; Tsigkos S; Vassilakopoulos T; Cottin T; Zhou Z; Gourzoulidou E; Roussos C; Waldmann H; Giannis A; Papapetropoulos A
Br J Pharmacol; 2007 Dec; 152(8):1207-14. PubMed ID: 17965739
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding TUG1 promotes angiogenesis of HUVECs in PE via regulating the miR-29a-3p/VEGFA and Ang2/Tie2 pathways.
Liu Z; Guo N; Zhang XJ
Microvasc Res; 2022 Jan; 139():104231. PubMed ID: 34352236
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor activates the Tie family of receptor tyrosine kinases.
Singh H; Milner CS; Aguilar Hernandez MM; Patel N; Brindle NP
Cell Signal; 2009 Aug; 21(8):1346-50. PubMed ID: 19376222
[TBL] [Abstract][Full Text] [Related]
13. Complementary actions of melatonin on angiogenic factors, the angiopoietin/Tie2 axis and VEGF, in co‑cultures of human endothelial and breast cancer cells.
González-González A; González A; Alonso-González C; Menéndez-Menéndez J; Martínez-Campa C; Cos S
Oncol Rep; 2018 Jan; 39(1):433-441. PubMed ID: 29115538
[TBL] [Abstract][Full Text] [Related]
14. The Tie2 receptor antagonist angiopoietin-2 in systemic lupus erythematosus: its correlation with various disease activity parameters.
Salama MK; Taha FM; Safwat M; Darweesh HE; Basel ME
Immunol Invest; 2012; 41(8):864-75. PubMed ID: 22989097
[TBL] [Abstract][Full Text] [Related]
15. IL-35 Inhibits Angiogenesis through VEGF/Ang2/Tie2 Pathway in Rheumatoid Arthritis.
Jiang S; Li Y; Lin T; Yuan L; Li Y; Wu S; Xia L; Shen H; Lu J
Cell Physiol Biochem; 2016; 40(5):1105-1116. PubMed ID: 27960151
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of proliferation, sprouting, tube formation and Tie2 signaling of lymphatic endothelial cells by the histone deacetylase inhibitor SAHA.
Cheng HT; Hung WC
Oncol Rep; 2013 Aug; 30(2):961-7. PubMed ID: 23754070
[TBL] [Abstract][Full Text] [Related]
17. Pro-Angiogenic Actions of CMC-Derived Extracellular Vesicles Rely on Selective Packaging of Angiopoietin 1 and 2, but Not FGF-2 and VEGF.
Wysoczynski M; Pathan A; Moore JB; Farid T; Kim J; Nasr M; Kang Y; Li H; Bolli R
Stem Cell Rev Rep; 2019 Aug; 15(4):530-542. PubMed ID: 31102187
[TBL] [Abstract][Full Text] [Related]
18. Endothelial TIE1 Restricts Angiogenic Sprouting to Coordinate Vein Assembly in Synergy With Its Homologue TIE2.
Cao X; Li T; Xu B; Ding K; Li W; Shen B; Chu M; Zhu D; Rui L; Shang Z; Li X; Wang Y; Zheng S; Alitalo K; Liu G; Tang J; Kubota Y; He Y
Arterioscler Thromb Vasc Biol; 2023 Aug; 43(8):e323-e338. PubMed ID: 37317851
[TBL] [Abstract][Full Text] [Related]
19. The role of the Angiopoietins in vascular morphogenesis.
Thomas M; Augustin HG
Angiogenesis; 2009; 12(2):125-37. PubMed ID: 19449109
[TBL] [Abstract][Full Text] [Related]
20. The role of Ang/Tie signaling in lymphangiogenesis.
Wu X; Liu N
Lymphology; 2010 Jun; 43(2):59-72. PubMed ID: 20848993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
